Glycobiology Advance Access published online on December 8, 2004
Glycobiology, doi:10.1093/glycob/cwi021
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratório de Tecido Conjuntivo, Hospital Universitrio Clementino Fraga Filho,; Instituto de Bioquímica Médica,
* To whom correspondence should be addressed. A linear sulfated fucan with a regular repeating sequence of [3)-
Received September 16, 2004
Revised November 30, 2004
Accepted December 2, 2004
Article
Selective cleavage and anticoagulant activity of a sulfated fucan: Stereospecific removal of a 2-sulfate ester from the polysaccharide by mild acid hydrolysis, preparation of oligosaccharides and heparin cofactor II-dependent anticoagulant activity
2 Laboratório de Tecido Conjuntivo, Hospital Universitrio Clementino Fraga Filho,; Instituto de Ciências Biomédicas,
3 Instituto de Bioquímica Médica,; Centro Nacional de Ressonância Nuclear Magnética de Macromoléculas, Universidade Federal do Rio de Janeiro, Caixa Postal 68041, Rio de Janeiro, RJ, 21941-590, Brazil and
4 Division of Hematology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, 63110, USA
Paulo A.S. Mouro, E-mail: pmourao{at}hucff.ufrj.br.
![]()
Abstract
-L-Fucp-(2SO4)- (1
3)-
-L-Fucp-(4SO4)-(1
3)-
-L-Fucp-(2,4SO4)-(1
3)-
-L-Fucp-(2SO4)-(1
]n is an anticoagulant polysaccharide mainly due to thrombin inhibition mediated by heparin cofactor II. No specific enzymatic or chemical method is available for the preparation of tailored oligosaccharides from sulfated fucans. We now employed an apparently non-specific approach to cleave this polysaccharide based on mild hydrolysis with acid. Surprisingly, the linear sulfated fucan was cleaved by mild acid hydrolysis on an ordered sequence. Initially a 2-sulfate ester of the first fucose unit is selectively removed. Thereafter, the glycosidic linkage between the nonsulfated fucose residue and the subsequent 4-sulfated residue is preferentially cleaved by acid hydrolysis, forming oligosaccharides with well-defined size. The low-molecular-weight derivatives obtained from the sulfated fucan were employed to determine the requirement for interaction of this polysaccharide with heparin cofactor II and to achieve complete thrombin inhibition. The linear sulfated fucan requires significantly longer chains than mammalian glycosaminoglycans to achieve anticoagulant activity. A slight decrease in the molecular size of the sulfated fucan dramatically reduces its effect on thrombin inactivation mediated by heparin cofactor II. Sulfated fucan with
45 tetrasaccharide repeating units binds to heparin cofactor II but is unable to link efficiently the plasma inhibitor and thrombin. This last effect requires chains with
100 or more tetrasaccharide repeating units. We speculate that the template mechanism may predominate over the allosteric effect in the case of the linear sulfated fucan inactivation of thrombin in the presence of heparin cofactor II.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. O. Castro, V. H. Pomin, L. L. Santos, A.-C. E. S. Vilela-Silva, N. Hirohashi, L. Pol-Fachin, H. Verli, and P. A. S. Mourao A Unique 2-Sulfated {beta}-Galactan from the Egg Jelly of the Sea Urchin Glyptocidaris crenularis: CONFORMATION FLEXIBILITY VERSUS INDUCTION OF THE SPERM ACROSOME REACTION J. Biol. Chem., July 10, 2009; 284(28): 18790 - 18800. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H Pomin and P. A S Mourao Structure, biology, evolution, and medical importance of sulfated fucans and galactans Glycobiology, December 1, 2008; 18(12): 1016 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H C Farias, V. H Pomin, A.-P. Valente, H. B Nader, H. A O Rocha, and P. A S Mourao A preponderantly 4-sulfated, 3-linked galactan from the green alga Codium isthmocladum Glycobiology, March 1, 2008; 18(3): 250 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prasad, D. Lillicrap, A. Labelle, S. Knappe, T. Keller, E. Burnett, S. Powell, and K. W. Johnson Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A Blood, January 15, 2008; 111(2): 672 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cumashi, N. A. Ushakova, M. E. Preobrazhenskaya, A. D'Incecco, A. Piccoli, L. Totani, N. Tinari, G. E. Morozevich, A. E. Berman, M. I. Bilan, et al. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds Glycobiology, May 1, 2007; 17(5): 541 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Pomin, A. P. Valente, M. S. Pereira, and P. A.S. Mourao Mild acid hydrolysis of sulfated fucans: a selective 2-desulfation reaction and an alternative approach for preparing tailored sulfated oligosaccharides Glycobiology, December 1, 2005; 15(12): 1376 - 1385. [Abstract] [Full Text] [PDF] |
||||


